Protagonist Therapeutics Inc (PTGX)

Inventory turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	1,712	2,544	3,371	3,300	3,312	2,736	2,762	2,784	2,785	3,348	2,495	1,652	819	0	0	0	0	0	0	2,774
Inventory	US$ in thousands	—	—	0	—	—	-2,050	-50	-51	-94	-620	—	7,729	8,503	—	0	0	3,976	10	10	10
Inventory turnover		—	—	—	—	—	—	—	—	—	—	—	0.21	0.10	—	—	—	0.00	0.00	0.00	277.40

December 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $1,712K ÷ $—K
= —

The inventory turnover ratio reflects how efficiently a company manages its inventory by indicating the number of times inventory is sold and replaced within a specific period. In the case of Protagonist Therapeutics Inc, the inventory turnover for the period ending March 31, 2020, stood at an exceptionally high value of 277.40, suggesting a rapid turnover of inventory.

However, from June 30, 2020, to December 31, 2021, the inventory turnover dropped to 0.00, indicating a significant decrease in the efficiency of managing inventory during this period. The absence of turnover may suggest issues such as overstocking or slow sales, which can tie up capital and lead to obsolescence risks.

From December 31, 2021, to March 31, 2022, there was a slight improvement in the inventory turnover ratio to 0.10, showing a modest increase in managing inventory. The value further improved to 0.21 by June 30, 2022, reflecting a more efficient management of inventory compared to the previous periods.

As of the latest available data, no turnover values were reported from September 2022 onwards, denoted by "\u2014", limiting the ability to assess the current efficiency of Protagonist Therapeutics Inc in managing its inventory. It is essential for the company to regularly monitor and improve its inventory turnover to optimize working capital and enhance profitability in the long run.